See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411158_2015_Anacor_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001411158, Anacor Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 160,570,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,642,000 |
| 3 | remainder_Assets | 46,835,000 |
| 4 | LiabilitiesCurrent | 28,653,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,392,000 |
| 9 | ResearchAndDevelopmentExpense | 72,493,000 |
| 10 | remainder_Expenses | 1,856,000 |
| 11 | remainder_Revenues | 20,686,000 |
| 12 | remainder_NetIncome | -2,091,000 |
| 13 | remainder_ComprehensiveNetIncome | -143,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 209,047,000 |
| 1 | Liabilities | 28,653,000 |
| 2 | Expenses | 105,741,000 |
| 3 | Revenues | 20,686,000 |
| 4 | StockholdersEquity | 180,394,000 |
| 5 | NetIncome | -87,146,000 |
| 6 | ComprehensiveNetIncome | -87,217,500 |
| 7 | BaseVar | 183,180,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.58 |
| 9 | EconomicCapitalRatio | 3.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
